GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.530
-0.260 (-5.43%)
At close: Aug 1, 2025, 4:00 PM
4.600
+0.070 (1.55%)
After-hours: Aug 1, 2025, 7:24 PM EDT
Theseus Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$6.33
Upside
+39.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $6 → $5.25 | Hold | Maintains | $6 → $5.25 | +15.89% | May 13, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +10.38% | May 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +54.53% | Apr 29, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $6.5 → $5.5 | Hold | Maintains | $6.5 → $5.5 | +21.41% | Apr 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +76.60% | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +37.97% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +32.45% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +32.45% | Dec 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +54.53% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +32.45% | Nov 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +120.75% | Aug 16, 2024 |
| UBS | UBS | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +87.64% | Aug 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +120.75% | Aug 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $9.5 | Hold | Maintains | $7 → $9.5 | +109.71% | Jun 10, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $8 → $10 | Hold → Buy | Upgrades | $8 → $10 | +120.75% | May 23, 2024 |
| Barclays | Barclays | Buy Maintains $9 → $10 | Buy | Maintains | $9 → $10 | +120.75% | May 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.